The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abramson, S. L.
Right arrow Articles by Gallin, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abramson, S. L.
Right arrow Articles by Gallin, J. I.

The Journal of Immunology, Vol 144, Issue 2 625-630, Copyright © 1990 by American Association of Immunologists


ARTICLES

IL-4 inhibits superoxide production by human mononuclear phagocytes

SL Abramson and JI Gallin
Bacterial Diseases Section, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892.

The activation of mononuclear phagocytes (M phi) and their generation of oxidative products is influenced by various cytokines as well as by normal maturational changes. We examined the effects of IL-4 on superoxide (O2-) production (cytochrome c reduction) by cultured M phi and the modulation of these effects by IFN-gamma and IL-1. Incubation of IL-4 (200 U/ml) with M phi inhibited M phi PMA (100 ng/ml)- stimulated O2-. production by 23% at 24 h, 34% at 48 h, and 70 to 85% at 72 to 96 h. IL-4 similarly inhibited M phi O2-. production in response to zymosan. IL-4 did not affect M phi viability, adherence to microtiter plates, or ability to phagocytose boiled yeast. In comparison with M phi, neutrophil O2-. production was not inhibited after 4 to 20 h incubation with IL-4. When IL-4 was washed out as early as 1 h after the initiation of M phi culture, significant inhibition of O2-. production was observed 4 days later. Sequential addition of either IL-4 or IFN-gamma to cultures demonstrated reciprocal cytokine effects on M phi; IL-4 partially inhibited O2-. production by M phi previously treated with rIFN-gamma whereas rIFN-gamma partially augmented O2-. production by M phi previously treated with IL-4. Because IL-4 has been reported to inhibit IL-1 production, add-back experiments were performed; addition of IL-1 only partly reconstituted O2-. production in IL-4-treated cells. Further characterization showed that although M phi protein synthesis was enhanced by both rIFN-gamma and IL-4 treatment, acid phosphatase, a marker of maturation to the macrophage phenotype, was markedly increased at an earlier time point in IL-4-treated M phi, and correlated with a decline in O2-. production. The ability of IL-4 to suppress M phi O2-. production implicates IL-4 as an important regulator of this aspect of the inflammatory response.


This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas
Theiler's Virus Infection: a Model for Multiple Sclerosis
Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Pilette, Y. Ouadrhiri, J. Van Snick, J.-C. Renauld, P. Staquet, J.-P. Vaerman, and Y. Sibille
IL-9 Inhibits Oxidative Burst and TNF-{alpha} Release in Lipopolysaccharide-Stimulated Human Monocytes Through TGF-{beta}
J. Immunol., April 15, 2002; 168(8): 4103 - 4111.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. A. Munger, A. Montero, M. Fukunaga, S. Uda, T. Yura, E. Imai, Y. Kaneda, J. M. Valdivielso, and K. F. Badr
Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis
PNAS, November 9, 1999; 96(23): 13375 - 13380.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
W. T. Shearer, M. W. Kline, S. L. Abramson, T. Fenton, S. E. Starr, and S. D. Douglas
Recombinant Human Gamma Interferon in Human Immunodeficiency Virus-Infected Children: Safety, CD4+-Lymphocyte Count, Viral Load, and Neutrophil Function (AIDS Clinical Trials Group Protocol 211)
Clin. Vaccine Immunol., May 1, 1999; 6(3): 311 - 315.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. K. Levings and J. W. Schrader
IL-4 Inhibits the Production of TNF-{alpha} and IL-12 by STAT6-Dependent and -Independent Mechanisms
J. Immunol., May 1, 1999; 162(9): 5224 - 5229.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Shibata, L. A. Foster, M. Kurimoto, H. Okamura, R. M. Nakamura, K. Kawajiri, J. P. Justice, M. R. Van Scott, Q. N. Myrvik, and W. J. Metzger
Immunoregulatory Roles of IL-10 in Innate Immunity: IL-10 Inhibits Macrophage Production of IFN-{gamma}-Inducing Factors but Enhances NK Cell Production of IFN-{gamma}
J. Immunol., October 15, 1998; 161(8): 4283 - 4288.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. A. Folcik, R. Aamir, and M. K. Cathcart
Cytokine Modulation of LDL Oxidation by Activated Human Monocytes
Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 1954 - 1961.
[Abstract] [Full Text]


Home page
BloodHome page
H. Niiro, T. Otsuka, K. Izuhara, K. Yamaoka, K. Ohshima, T. Tanabe, S. Hara, Y. Nemoto, Y. Tanaka, H. Nakashima, et al.
Regulation by Interleukin-10 and Interleukin-4 of Cyclooxygenase-2 Expression in Human Neutrophils
Blood, March 1, 1997; 89(5): 1621 - 1628.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Sozzani, C. Cambon, N. Vita, M.-Hélèn. Séguélas, D. Caput, P. Ferrara, and B. Pipy
Interleukin-13 Inhibits Protein Kinase C-triggered Respiratory Burst in Human Monocytes
J. Biol. Chem., March 10, 1995; 270(10): 5084 - 5088.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.